The stained tissue sections demonstrated that the expression of VEGFD was robust in the P38 tumour sample, bearing the COL4A1‐VEGFD gene fusion, compared to patient P46, used as negative control (Figure 2C,D). This evidence concerns the gene VEGFD and neoplasm.